
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Citius Oncology (NASDAQ:CTOR) through any online brokerage.
Other companies in Citius Oncology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Citius Oncology has a consensus price target of $6.00.
The stock price for Citius Oncology (NASDAQ: CTOR) is $0.94 last updated September 9, 2026 at 7:14 PM EDT.
There are no upcoming dividends for Citius Oncology.
Citius Oncology does not have any upcoming earnings scheduled.
There is no upcoming split for Citius Oncology.
Citius Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.